Table 2.
Outcomes at Six Months by Discharge Destination
| N | Unadjusted rates |
Adjusteda
rates |
|||||
|---|---|---|---|---|---|---|---|
| SNF n (%) | Home n (%) | Home health n (%) | SNF | Home | Home health | ||
| Patients, n | 3275 | 90 | 2580 | 605 | 90 | 2580 | 605 |
| 30 days readmit | 3275 | 30 (33.3) | 775 (30.0) | 135 (22.3) | 28.5 | 30.4 | 21.7 |
| Death | 3275 | 45 (50.0) | 470 (18.2) | 121 (20.0) | 39.8 | 18.5 | 19.3 |
| Hospiceb | 636 | 17 (37.8) | 238 (50.6) | 72 (59.5) | 38.9 | 50.9 | 58.1 |
| Hospice LOS <3 daysb | 636 | 8 (17.8) | 166 (35.3) | 48 (39.7) | 21.3 | 34.9 | 39.4 |
| Chemotherapy | 3275 | 22 (24.4) | 1229 (47.6) | 251 (41.5) | 25.7 | 47.5 | 41.8 |
| Radiation | 3275 | 13 (14.4) | 595 (23.1) | 139 (23.0) | 12.6 | 23.3 | 22.4 |
| Targeted treatment | 3275 | 1 (1.1) | 155 (6.0) | 36 (3.0) | 1.3 | 5.9 | 6.1 |
| ED visit | 3275 | 24 (26.7) | 833 (32.3) | 209 (34.6) | 24.2 | 32.7 | 33.4 |
| Chemotherapy before deathc | 2178 | 21 (21.0) | 1193 (36.7) | 252 (30.9) | 20.8 | 36.6 | 31.2 |
| Radiation before deathc | 2178 | 17 (17.3) | 755 (22.4) | 158 (20.0) | 16.0 | 22.4 | 20.0 |
| Targeted chemotherapy before deathc | 2178 | 5 (6.2) | 229 (8.4) | 59 (8.6) | 7.5 | 8.3 | 8.7 |
a
Adjusted for age, sex, race, stage at diagnosis, primary payer, and comorbidities.
b
Only among those who died in six-month follow-up.
c
Death at any point, not limited to six-month follow-up period.
ED, emergency department; LOS, length of stay.